-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tau pathology, in the form of neurofibrillary tangles (NFT) of hyperphosphorylated tau, together with amyloid beta (Aβ) plaques, is one of the hallmarks of Alzheimer's disease (AD)
On the other hand, Aβ42 showed a decrease in CSF level
immunity
However, some studies have shown that tau in CSF is very heterogeneous.
In a recent study, Kaj et al.
diagnosis
In the non-AD group, N-224 was found in Parkinson’s disease (PD, p <0.
The important significance of this study lies in the discovery: N-224 tau can distinguish AD subjects from SCD, and can distinguish between subgroups of non-AD dementia and AD
N-224 tau can distinguish AD subjects from SCD, and can distinguish subgroups of non-AD dementia and AD
Leave a message here